What was the Michigan Pre-Seed Fund III, an East Lansing fund created to put money into start-up and really early stage corporations, doing investing in Genomenon Inc., a 6-year-old Ann Arbor firm that had beforehand raised virtually $5 million in fairness funding and obtained practically $2 million in three grants from the Nationwide Institutes of Well being?
Why was the fund, doing enterprise as Michigan Rise and a wholly-owned subsidiary of the Michigan State College Basis, investing in a 2014 spinoff from the College of Michigan?
Doing the correct factor, mentioned Jeff Wesley, govt director of each Michigan Rise and of Pink Cedar Ventures, one other funding arm of the MSU Basis. He was stepping in to assist a revered well being care firm that was in a monetary bind due to COVID, and serving to Mike Klein, a extremely revered CEO with an extended observe report.
“Due to COVID, Mike wanted assist fundraising. I’ve recognized him since his Steeplechase days. Genomenon would usually be previous our curiosity as a pre-seed fund, however we love the well being care area and we love Mike. We stepped in,” mentioned Wesley. Pink Cedar additionally invested within the emergency fundraising.
When COVID hit, Klein mentioned Genomenon was elevating a funding spherical focused at $5 million and had 5 institutional buyers prepared to jot down checks. Genomenon has developed a number of cloud-based software program instruments that automate the interpretation of genome sequencing to assist diagnose and deal with sufferers affected by uncommon genetic illnesses.
On March 13, 2020, the corporate’s staff started working remotely. “By the subsequent week, each investor had pulled again,” mentioned Klein. “They advised us, ‘We’ll deal with our present portfolio. We do not know the place that is going.’ We had sufficient cash to get to summer time, however that was it. It was a very scary setting. The world had collapsed. Nobody had any concept what was taking place.”
To the rescue got here a few of Genomon’s earlier buyers and a few new ones, which included each Michigan Rise and Pink Cedar Ventures, elevating $3 million in convertible notes that would later be transformed to fairness when and if Genomenon was capable of increase an fairness spherical. That fairness spherical closed this previous March at $5.3 million.
Previous buyers becoming a member of the fairness spherical included Make investments Detroit and Make investments Michigan, the primary two pre-seed funds launched by the Michigan Financial Growth Corp..
The convertible-note $3 million bridge spherical helped Genomenon flourish regardless of COVID. It added 10 staff after the pandemic hit for a complete of 26, and with working at residence the brand new regular was capable of recruit expertise in California, South Carolina and Pennsylvania that will not have wished to maneuver to Michigan.
By the top of Might, the corporate had surpassed income for all of 2020, and that yr it had doubled its income over 2019.
“We’re approaching cash-flow constructive,” mentioned Klein. “We might do one other funding spherical subsequent yr, however we might not need to.”
Klein was named CEO in 2015, the identical yr the corporate received $100,000 because the runner-up on the annual Speed up Michigan Innovation competitors in Detroit.
In 1993, Klein based Ann Arbor-based Steeplechase Software program Inc., which introduced PC-based automation to the manufacturing unit ground. It was bought in 2000 to Schneider Automation.
From 2001-2008 he was CEO at Ann Arbor-based Interlink Networks Inc., a College of Michigan spinoff offering community safety.
Earlier than becoming a member of Genomenon, he was co-CEO of Ann Arbor-based On-line Tech LLC, one of many state’s greatest knowledge storage and cloud-services corporations, with 4 knowledge facilities in Michigan and one in Indianapolis.